We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current RPID market cap is 46.91M. The company's latest EPS is USD -1.2192 and P/E is -0.89.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 6.15M | 6.34M | 5.61M | 6.62M | 7.6M |
Operating Income | -14.45M | -12.19M | -14.27M | -13.38M | -12.04M |
Net Income | -13.39M | -11.17M | -13.32M | -12.58M | -11.32M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 16.51M | 16.08M | 23.23M | 17.13M | 22.52M |
Operating Income | -18.63M | -30.54M | -47.23M | -63.22M | -56.56M |
Net Income | -26.62M | -45.22M | -78.03M | -60.81M | -52.47M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 150.16M | 143.45M | 127.73M | 117.09M | 105.84M |
Total Liabilities | 22.38M | 25.46M | 21.79M | 22.5M | 21.47M |
Total Equity | 127.79M | 117.99M | 105.94M | 94.59M | 84.37M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 31.69M | 70M | 241.17M | 190.65M | 143.45M |
Total Liabilities | 32.41M | 45.18M | 20.19M | 26.48M | 25.46M |
Total Equity | -82.58M | -127.01M | 220.98M | 164.17M | 117.99M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -35.58M | -45.08M | -15.53M | -25.64M | -34.24M |
Investing | 32.15M | 42.15M | 13.52M | 38.33M | 31.79M |
Financing | 161k | 149k | 158k | 148k | 209k |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -21.15M | -31M | -54.96M | -58.55M | -45.08M |
Investing | -1.7M | -15.67M | -13.29M | -93.47M | 42.15M |
Financing | 14.87M | 64.23M | 216.75M | 693k | 149k |
Market Cap | 46.91M |
Price to Earnings Ratio | -0.89 |
Price to Sales Ratio | 2.08 |
Price to Cash Ratio | 1.93 |
Price to Book Ratio | 0.4 |
Dividend Yield | - |
Shares Outstanding | 43.03M |
Average Volume (1 week) | 105.97k |
Average Volume (1 Month) | 83.21k |
52 Week Change | 14.74% |
52 Week High | 1.45 |
52 Week Low | 0.58 |
Spread (Intraday) | 0.07 (5.3%) |
Company Name | Rapid Micro Biosystems Inc |
Address |
251 little falls drive delaware, ohio 19808 |
Website | https:///www.rapidmicrobio.com |
Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions